Identifying specific needs in adult cystic fibrosis patients: a pilot study using a custom questionnaire

Sandra Dury, Jeanne-Marie Perotin, Bruno Ravoninjatovo, Catherine Llerena, Julien Ancel, Pauline Mulette, Muriel Griffon, Sophie Carré, Amélie Perrin, François Lebargy, Gaëtan Deslée, Claire Launois, Sandra Dury, Jeanne-Marie Perotin, Bruno Ravoninjatovo, Catherine Llerena, Julien Ancel, Pauline Mulette, Muriel Griffon, Sophie Carré, Amélie Perrin, François Lebargy, Gaëtan Deslée, Claire Launois

Abstract

Background: Adult patients with cystic fibrosis (CF) experience daily physical symptoms and disabilities that can be challenging to address for health care teams.

Methods: We sought to identify the most frequent topics that CF adults need to discuss with health care teams using a custom questionnaire including 62 items.

Results: Fifty patients were included, 70% men, mean age 27.6 years, with a mean body mass index of 21.8 kg/m2. Mean FEV1% was 64% of predicted value. Forty-two percent of patients selected at least one topic. The most frequently selected topics were fatigue (20%), professional or scholar worries (18%), procreation (16%), physical activities (16%) and evolution of CF disease (16%). Women were more frequently concerned about fatigue, procreation and profession/school.

Conclusions: Using a custom questionnaire, we identified that CF adults express various unmet needs that extend beyond usual respiratory and nutritional concerns or treatment adherence. The interest of this questionnaire by health care team for improving therapeutic management of CF patients remains to be validated.

Trial registration: The study was registered on ClinicalTrials.gov (NCT02924818) on 5th October 2016.

Keywords: Cystic fibrosis; Fatigue; Needs; Quality of life; Questionnaire.

Conflict of interest statement

SD reports reimbursements from Novartis and Boehringer Ingelheim, and personal fees from Chiesi outside the submitted work. BR reports reimbursements from Novartis, Mylan, Vertex, Vitalair and Reckitt Benckiser. CLL reports personal fees from Zambon outside the submitted work. MG reports reimbursements from Novartis and Zambon. SC reports reimbursements from Novartis and Vitalaire. FL reports reimbursements from Boehringer Ingelheim and personal fees from Novartis, Boehringer Ingelheim and GlaxoSmithKline outside the submitted work. GD reports personal fees from Nuvaira, AstraZeneca, Boehringer Ingelheim, Chiesi, BTG-PneumRx, and Novartis outside the submitted work.

© 2021. The Author(s).

References

    1. Steinkamp G, Wiedemann B, on behalf of the german CFQA Group Relationship between nutritional status and lung function in cystic fibrosis: cross sectional and longitudinal analysis from the German CF quality assurance (CFQA) Thorax. 2002;57:596–601. doi: 10.1136/thorax.57.7.596.
    1. Elborn JS. Cystic fibrosis. Lancet. 2016;388:2519–2531. doi: 10.1016/S0140-6736(16)00576-6.
    1. US Cystic Fibrosis Registry (Cystic Fibrosis Foundation). Annual data report 2019.
    1. Sawicki GS, Sellers DE, Robinson WM. Self-reported physical and psychological symptom burden in adults with cystic fibrosis. J Pain Symptom Manag. 2008;35(4):372–380. doi: 10.1016/j.jpainsymman.2007.06.005.
    1. Quittner AL, Goldbeck L, Abbott J, Duff A, Lambrecht P, Solé A, Tibosch MM, Bergsten brucefors A, Yüksel H, Catastini P, Blackwell L, Barker D. Prevalence of depression and anxiety in adults with cystic fibrosis and parent caregivers: results of The International Depression Epidemiological Study across nine countries. Thorax. 2014;69(12):1090–1097. doi: 10.1136/thoraxjnl-2014-205983.
    1. Sawicki GS, Sellers DE, McGuffie K, Robinson W. Adults cystic fibrosis report important and unmet needs for disease information. J Cyst Fibros. 2007;6:411–416. doi: 10.1016/j.jcf.2007.03.004.
    1. Lonabaugh KP, O’Neal KS, McIntosh H, Condren M. Cystic fibrosis-related education: are we meeting patient and caregiver expectations? Patient Educ Couns. 2018;101(10):1865–1870. doi: 10.1016/j.pec.2018.06.004.
    1. Trandel ET, Pilewski JM, Dellon EP, Moreines LT, Yabes JG, Jeong K, Kavalieratos D. Symptom burden and unmet existential needs in adults with cystic fibrosis. West J Nurs Res. 2019;41(10):1448–1464. doi: 10.1177/0193945919852585.
    1. Riekert KA, Bartlett SJ, Boyle MP, Krishnan JA, Rand CS. The association between depression, lung function, and health-related quality of life among adults with cystic fibrosis. Chest. 2007;132:231–237. doi: 10.1378/chest.06-2474.
    1. .
    1. Padilla A, Olveira G, Olveira C, Dorado A, Plata AJ, Gaspar I, Pérez-Frias J. Validity and reliability of the St George’s respiratory questionnaire in adults with cystic fibrosis. Arch Bronchoneumol. 2007;43(4):205–211.
    1. Lee TWR, Brownlee KG, Conway SP, Denton M, Littelwood JM. Evaluation of a new definition for chronic Pseudomonas aeruginosa infection in cystic fibrosis patients. J Cyst Fibros. 2003;21(1):29–34. doi: 10.1016/S1569-1993(02)00141-8.
    1. Widerman E. Knowledge, interests and educational needs of adults diagnosed with cystic fibrosis after age 18. J Cyst Fibros. 2003;2:97–104. doi: 10.1016/S1569-1993(03)00026-2.
    1. Obregon LL, Jeong K, Hoydich ZP, Yabes J, Pilewski J, Richless C, Moreines LT, Dellon EP, Goss CH, Arnold RM, Kavalieratos D. Associations between demographic characteristics and unmet supportive care needs in adults with cystic fibrosis. BMJ Support Palliat Care 2019:14.
    1. Nap-van der Vlist MM, Burghard M, Hulzebos HJ, Doeleman WR, Heijerman HGM, van der Ent CK, Nijhof SL. Prevalence of severe fatigue among adults with cystic fibrosis: a single center study. J Cyst Fibros. 2018;17:368–374. doi: 10.1016/j.jcf.2018.03.003.
    1. Jarad NA, Sequeiros IM, Patel P, Bristow K, Sund Z. Fatigue in cystic fibrosis: a novel prospective study investigating subjective and objective factors associated with fatigue. Chron Respir Dis. 2012;9(4):241–249. doi: 10.1177/1479972312464236.
    1. Targett K, Bourke S, Nash E, Murphy E, Ayres J, Devereux G. Employment in adults with cystic fibrosis. Occup Med. 2014;64:87–94. doi: 10.1093/occmed/kqt140.
    1. Kwong E, Desai S, Chong L, Lee K, Zheng J, Wilcox PG, Quon BS. The impact of cystic fibrosis-related diabetes on health-related quality of life. J Cyst Fibros. 2019;18:734–736. doi: 10.1016/j.jcf.2019.03.007.
    1. Hames A, Beesley J, Nelson R. Cystic fibrosis: what do patients know, and what else would they like to know? Respir Med. 1991;85:389–392. doi: 10.1016/S0954-6111(06)80183-6.
    1. Kazmerski TM, Nelson EB, Newman LR, Haviland M, Luff D, Leichtner AM, Hayes MM, Miller E, Emans SJ, Sawicki GS. Interprofessional provider educational needs and preferences regarding the provision of sexual and reproductive health care in cystic fibrosis. J Cyst Fibros. 2019;18:671–676. doi: 10.1016/j.jcf.2019.01.015.
    1. Kazmerski TM, Sawicki GS, Miller E, Jones KA, Abebe KZ, Tuchman LK, Ladores S, Rubenstein RC, Sagel SD, Weiner DJ, Pilewski JM, Orenstein DM, Borrero S. Sexual and reproductive health care utilization and preferences reported by young women in cystic fibrosis. J Cyst Fibros. 2018;17:64–70. doi: 10.1016/j.jcf.2017.08.009.
    1. Moen IE, Nilsson K, Andersson A, Fagerland MW, Fluge G, Hollsing A, Gilljam M, Mared L, Pressler T, Santi H, Storrosten OT, Hjelte L. Dietary intake and nutritional status in a Scandinavian adult cystic fibrosis-population compared with recommandations. Food Nutr Res. 2011;55:7561. doi: 10.3402/fnr.v55i0.7561.
    1. Ledder O, Haller W, Couper RT, Lewindon P, Oliver M. Cystic fibrosis: an update for clinicians. Part 2: hepatobiliary and pancreatic manifestations. J Gastroenterol Hepatol. 2014;29(12):1954–1962. doi: 10.1111/jgh.12785.
    1. Laguna TA, Nathan BM, Moran A. Managing diabetes in cystic fibrosis. Diabetes Obes Metab. 2010;12(10):858–864. doi: 10.1111/j.1463-1326.2010.01250.x.
    1. Knapp EA, Fink AK, Goss CH, Sewall A, Ostrenga J, Dowd C, Elbert A, Petren KM, Marshall BC. The cystic fibrosis foundation patient registry. Design and methods of a national observational disease registry. Ann Am Thorac Soc. 2016;13(7):1173–1179. doi: 10.1513/AnnalsATS.201511-781OC.

Source: PubMed

Sponsors and Collaborators

Medical Conditions

Drug Interventions

3
Subscribe